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ynamic regulation of 
 
 
 
-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid receptors (AMPARs)
underlies aspects of synaptic plasticity. Although
numerous AMPAR-interacting proteins have been identi-
ﬁed, their quantitative and relative contributions to native
AMPAR complexes remain unclear. Here, we quantitated
protein interactions with neuronal AMPARs by immuno-
precipitation from brain extracts. We found that stargazin-
like transmembrane AMPAR regulatory proteins (TARPs)
copuriﬁed with neuronal AMPARs, but we found negligible
D
 
binding to GRIP, PICK1, NSF, or SAP-97. To facilitate
puriﬁcation of neuronal AMPAR complexes, we generated
a transgenic mouse expressing an epitope-tagged GluR2
subunit of AMPARs. Taking advantage of this powerful
new tool, we isolated two populations of GluR2 contain-
ing AMPARs: an immature complex with the endoplasmic
reticulum chaperone immunoglobulin-binding protein and
a mature complex containing GluR1, TARPs, and PSD-95.
These studies establish TARPs as the auxiliary components
of neuronal AMPARs.
 
Introduction
 
Most excitatory synapses in brain use glutamate as a neuro-
transmitter. Fast signaling at these synapses occurs primarily by
activation of 
 
 
 
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA)–type and 
 
N
 
-methyl-
 
D
 
-aspartate (NMDA)–type
glutamate receptors, and these two receptors sub-serve differ-
ent functions at the synapse. AMPA receptors (AMPARs) are
glutamate-gated monovalent cation channels whose activation
provides most of the postsynaptic depolarization that drives
neuronal firing. NMDA receptors are permeable both to
monovalents and to calcium, which induces synaptic plasticity.
This NMDA receptor-dependent synaptic plasticity involves
rapid changes in the density of synaptic AMPARs.
AMPAR channels comprise heterotetramers of subunits
GluR1–4 (Hollmann and Heinemann, 1994). Furthermore, a
variety of proteins can interact with AMPARs in vitro. Most of
these associated proteins were identified by yeast two-hybrid
screening using the cytoplasmic tails of AMPAR subunits.
Many AMPAR-interacting proteins contain PDZ motifs that
bind to the extreme COOH-terminal tails of specific AMPAR
subunits. The final four amino acids of GluR2/3 bind to the
PDZ proteins GRIP1/ABP and PICK1 (Dong et al., 1997;
Srivastava and Ziff, 1999; Xia et al., 1999). The COOH terminus
of GluR1 binds to the PDZ protein SAP-97 (Leonard et al.,
1998). More proximal regions of the AMPAR subunits can also
bind to non-PDZ proteins. The adaptor protein AP-2 and the
 
N
 
-ethyl maleimide sensitive factor NSF, which are proteins
involved in vesicle budding and fusion, bind to overlapping
regions in GluR2/3 (Song et al., 1998; Luthi et al., 1999; Noel
et al., 1999; Lee et al., 2002). Finally, the cytoskeletal protein
band 4.1N associates with GluR1 and 4 (Shen et al., 2000).
Genetic studies have not yet established that any of these inter-
actions with the cytoplasmic tails of AMPARs are essential for
receptor trafficking.
The first transmembrane protein found to interact with
AMPARs is stargazin (Chen et al., 2000), which is mutated in
stargazer mice (Letts et al., 1998). These mice show absence
epilepsy and lack functional AMPARs at cerebellar granule
cells (Chen et al., 1999, 2000; Hashimoto et al., 1999). Stargazin
plays two roles in trafficking AMPARs to synapses. First,
stargazin can associate with all four AMPAR subunits and traffic
them to the plasma membrane. Second, the extreme COOH
terminus of stargazin can bind to PSD-95 and other PDZ proteins
to mediate synaptic clustering of AMPARs (Chen et al., 2000).
Although AMPARs function normally in forebrain of stargazer
mice, a family of related transmembrane AMPAR regulatory
proteins (TARPs) is expressed in brain and can also traffic
AMPARs (Tomita et al., 2003). Therefore, the TARP mechanism
may be universal in trafficking AMPARs in all neurons. Despite
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this wealth of AMPAR binding proteins, their relative and quan-
titative contribution to neuronal AMPARs remains uncertain.
Also unclear is whether the cytoplasmic AMPAR-interacting
proteins and TARPs bind to distinct or overlapping populations
of AMPAR proteins. Here, we used immunoisolation studies to
quantitate protein interactions with neuronal AMPARs.
 
Results and discussion
 
We solubilized whole brain extracts with 1% Triton X-100 and
purified AMPAR complexes using a well-characterized anti-
body to GluR2. Under these conditions, 
 
 
 
10% of GluR2 was
isolated and along with it came 
 
 
 
7.5% of total GluR1 (Fig. 1
A). Recovery of TARPs showed similar efficiency. In contrast,
we were unable to detect any of the other reported AMPAR
binding proteins including GRIP, NSF, PICK1, or SAP-97
(Fig. 1, A and B).
To permit more efficient isolation of GluR2 complexes, we
designed an epitope-tagged GluR2 construct that has both a
FLAG-recognition site and a calmodulin-binding peptide (CBP),
which permit efficient and selective protein isolation from crude
homogenates (Yang et al., 2002; Fig. 2 A). We first used this
construct in heterologous expression systems and found that it
expressed an appropriate and functional GluR2. As expected, the
expressed protein migrated at a slightly larger monomeric molec-
ular mass than did GluR2 without the engineered tags (Fig. S1 A,
available at http://www.jcb.org/cgi/content/full/jcb.200501121/
DC1). We found that glutamate-evoked currents from this GluR2
expressed in 
 
Xenopus laevis 
 
oocytes were vastly increased by co-
expression of stargazin cRNA (Fig. 2 B). We also determined
that this construct was expressed appropriately on the surface of
transfected hippocampal neurons (Fig. 2 C).
Immunoaffinity purification (IAP) from transfected
HEK293T cells using FLAG antibody-conjugated agarose al-
Figure 1. Immunoisolation of AMPARs from wild-type mice. (A and B)
Brain extracts solubilized with 1% Triton X-100 were used for immuno-
precipitation with anti-GluR2 antibody or nonimmune mouse IgG. AMPAR
subunits and previously reported AMPAR binding proteins (see text) were
examined by immunoblotting. Input lanes contain the indicated percent-
age of proteins used for immunoprecipitation (IP). (A) The percentages of
binding (%) are indicated.
Figure 2. Functional expression of CBP/FLAG-GluR2 in heterologous cells
and in transgenic mouse brain. (A) Schematic presentation of CBP/FLAG-
GluR2. Calmodulin-binding peptide (CBP) and FLAG peptide sequences
were inserted after the signal sequence of mouse GluR2 (flop form edited
at position 586 (Q/R)). (B) In X. laevis oocytes expressing CBP/FLAG-
GluR2, glutamate-evoked currents were vastly increased by coexpression
of stargazin cRNA. (C) Surface receptors expressed in hippocampal neurons
were live labeled with anti-FLAG M2 and total GluR2 was stained with
anti-GluR2/3. Bar, 20  m. (D) More efficient isolation of CBP/FLAG-
GluR2 by immunoaffinity purification (IAP; anti-FLAG M2 agarose) than by
conventional immunoprecipitation (anti-GluR2 antibody). Almost 100% of
solubilized CBP/FLAG-GluR2 was isolated by IAP. FT, flow-through. (E)
Two-step purification of CBP/FLAG-GluR2. The extracts of HEK cells trans-
fected with mock vector or CBP/FLAG-GluR2 were subjected to sequential
affinity chromatography: IAP and calmodulin-affinity chromatography
(CaM). The arrow indicates the 110-kD protein (CBP/FLAG-GluR2). The
arrowhead indicates the copurified 78-kD protein (identified as BiP/
Grp78 by mass spectrometry). (F) Whole brain extracts (50  g) from the
indicated transgenic mouse lines and 100 fmol of CBP/FLAG-GluR2 puri-
fied from HEK cells were probed with the indicated antibodies. CBP/
FLAG-GluR2 represents  50% of the endogenous protein in line 917. (G)
Basal synaptic transmission is normal in transgenic GluR2 mice. (a) Input–
output curve for basal synaptic transmission in hippocampal slices from
wild type (Wt; n   16) and transgenic (Tg; n   18) mice. Each point
represents the mean   SEM for each bin. Sample fEPSPs at different stimulus
intensities are shown on top. Bars: (y-axis) 0.5 mV; (x-axis) 20 ms. (b)
AMPA/NMDA ratios were calculated by evoking dual-component EPSCs
(Wt, n   5; and Tg, n   9). Histogram represents the AMPA/NMDA ratio
mean    SEM. Sample traces of the mixed and isolated AMPA- and
NMDA-mediated EPSCs from wild-type and transgenic mice are shown on
top. Bars: (y-axis) 100 pA; (x-axis) 20 ms. 
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lowed us to quantitatively isolate the expressed GluR2. Immu-
noblot analysis revealed that GluR2 was more efficiently iso-
lated with the IAP method than with conventional anti-GluR2
immunoprecipitation (Fig. 2 D). Silver staining of eluates
showed specific bands of 110 and 78 kD (Fig. 2 E). These inter-
actions were specific because both protein bands copurified af-
ter the application to calmodulin resin. The 110 kD corresponds
to GluR2. Mass spectrometry analysis revealed that the 78-kD
protein is BiP/Grp78 (immunoglobulin binding protein/glucose
regulated protein 78), a ubiquitous protein chaperone that oc-
curs in the ER. Previous studies showed that BiP also binds to
AMPARs in brain extracts (Rubio and Wenthold, 1999).
To use our epitope-tagged construct for isolation of AM-
PAR complexes from brain, we developed a transgenic mouse
model. We put the CBP/FLAG-GluR2 construct downstream
of the Thy 1 promoter. Highest protein expression in brain was
found in line 917, and this line was used for subsequent studies
(Fig. 2 F and Fig. S1 B). As expected, the Thy 1 promoter
drove protein expression exclusively in brain and not in periph-
eral tissues (Fig. S1 C; Luthi et al., 1997). We found GluR2
transgene expression in the cerebral cortex, hippocampus, and
striatum and much less expression in the cerebellum (Fig. S1
D). Basal synaptic transmission in transgenic mice was not dif-
ferent from wild-type mice (Fig. 2 G).
We used brains from these mice to isolate neuronal AM-
PAR complexes. Forebrain extracts were solubilized with Tri-
ton X-100. Purification from transgenic mouse brain extracts
yielded protein bands of 110, 78, and 35 kD (Fig. 3 A). Quanti-
tative Western blotting showed that the 110-, 78-, and 35-kD
proteins corresponded to AMPAR subunits, BiP, and TARPs,
respectively (Fig. 3, A–C; and see Fig. 4). We saw no other
protein bands copurified specifically with AMPARs. As previ-
ously described (Tomita et al., 2004), when TARPs were im-
munoprecipitated from brain, a protein complex comprising
110- and 35-kD proteins, corresponding to AMPARs and
TARPs respectively, was isolated (Fig. 3 A).
To evaluate the composition of the endogenous AMPAR
complex more carefully, we used additional antibodies for
Western blotting (Fig. 3 B). Again, we found that GluR1,
GluR4, and TARPs copurified with FLAG-tagged GluR2. High
recovery of GluR1 and GluR4 indicates that physiologically
relevant AMPARs were isolated. In contrast, we found no sig-
nificant association of protein 4.1N, GRIP, AP-2, NSF, PICK1,
SAP-97, or SAP-102. We did find some association of PSD-95
with the purified AMPAR complex (Fig. 3, B and C). How-
ever, the recovery of PSD-95 was 
 
 
 
0.5%, which confirms that
PSD-95 does not directly bind to AMPARs (see Fig. 4) and in-
dicates that a large proportion of PSD-95 occurs in other neu-
ronal protein complexes. Quantitative Western blots revealed
that CBP/FLAG-GluR2, GluR1, and TARPS are at the molar
ratio of 
 
 
 
5:1:1 in the purified complex (Fig. 3 C; representa-
tive from five independent experiments). Our failure to isolate
previously reported binding proteins in our AMPAR complex
cannot be explained by poor recovery, as we isolated 
 
 
 
90% of
the solubilized GluR2 (Fig. 3 B and Fig. S1 E). We considered
that our conditions may not have solubilized synaptic AMPAR
complexes. Therefore, we repeated our procedure using deoxy-
cholate, which provides a more efficient extraction of cytoskel-
etal and synaptic proteins (Luo et al., 1997; Fig. S2, available
at http://www.jcb.org/cgi/content/full/jcb.200501121/DC1).
Deoxycholate severely reduced the recovery of purified AM-
PARs and TARPs, and increased nonspecific binding (Fig. S2,
Wt). However, we again found that TARPs interacted with
AMPARs more efficiently than other proteins.
We wondered whether our purification isolated a single
AMPAR complex or multiple ones with distinct compositions.
Figure 3. Quantitative association of TARPs with
immunopurified AMPARs. (A) Gold colloidal total
protein staining of immunoaffinity-purified CBP/FLAG-
GluR2 (IAP) and immunoprecipitated TARPs (IP). The
same preparations were also analyzed by Western
blotting with anti-GluR1 or TARP antibody. The pro-
teins with molecular masses of 110 (arrow), 78
(closed arrowhead), and 35 kD (open arrowhead)
were detected in the transgenic mouse (Tg) but not in
wild-type (Wt). 110- and 35-kD proteins were also
detected in TARPs-IP, which correspond to AMPARs
including GluR1 and TARPs, respectively. Asterisks
denote the bands of IgG heavy and light chains. (B)
IAP elution in A was immunoblotted with the indicated
antibodies. The recovery (%) of each protein from input
is indicated. (C) Quantitative binding of TARPs with
AMPARs. For CBP/FLAG-GluR2, GluR1, and TARPs,
input (1%) and purified AMPARs (IAP; 1%) from trans-
genic mouse brain were analyzed with the indicated
amounts of purified CBP/FLAG-GluR2, HA-GluR1, and
His6-stargazin COOH terminus. For PSD-95 and SAP-
97, input (0.1%) and IAP elution (4%) were analyzed
with purified PSD-95-GFP and SAP-97-GFP. These data
are representative of five independent experiments. 
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To address this question, we reprecipitated the protein com-
plexes with antibodies to either BiP or TARPs (Fig. 4). Silver
staining revealed that BiP reprecipitation quantitatively iso-
lated 110- and 78-kD proteins, whereas TARP reprecipitation
quantitatively isolated 110- and 35-kD proteins, confirming
that 78- and 35-kD protein bands that copurified with AM-
PARs (Fig. 3 A) are BiP and TARPs, respectively. The BiP re-
precipitation showed that this ER chaperone associates with
GluR2 alone, as we found no association with GluR1, PSD-95,
or TARPs. In contrast, we found that the TARP reprecipitates
contained both GluR1 and PSD-95. This finding suggests that
BiP binds to an immature GluR2 complex whereas TARPs
bind to a more mature one containing heteromeric GluR sub-
units and the synaptic tether PSD-95.
This study identified stargazin as the only major detect-
able auxiliary component of mammalian AMPARs. Our failure
to identify cytosolic AMPAR-binding proteins in immunopre-
cipitates from forebrain extracts conflicts with data and conclu-
sions from numerous previously published papers (Osten et al.,
1998, 2000; Nishimune et al., 1998; Song et al., 1998; Sriva-
stava et al., 1998; Luthi et al., 1999; Noel et al., 1999; Xia et al.,
1999; Daw et al., 2000; Perez et al., 2001; Hanley et al., 2002;
Lee et al., 2002; Wyszynski et al., 2002; Hirbec et al., 2003;
Lee et al., 2004). Reasons for this discrepancy are not clear, but
likely do not reflect differences in methodology; we carefully
followed previously published protocols and used at least two
kinds of solubilization conditions for all our experiments. One
possibility is that the previously published studies were not
done quantitatively and were not done with comparison to
TARPs. These studies may have identified minimal amounts of
cytosolic-interacting proteins that were dismissed as negligible
in our experiments. We cannot discount the possibility that
these previously identified AMPAR-interacting proteins bind
under specialized circumstances or bind to receptors that are
not solubilized in nondenaturing detergents. However, our pro-
tocol did solubilize 
 
 
 
90% of total AMPARs, so the previously
reported non-TARPs seem not to be general or core-interacting
proteins with the AMPAR complex.
Genetic analyses support our contention that stargazin, but
not other known proteins, plays a fundamental role in trafficking
of AMPARs. Mice lacking stargazin lack surface AMPARs in
specific neuronal populations (Hashimoto et al., 1999; Chen et
al., 2000). In addition to mediating synaptic AMPAR trafficking,
identified cytosolic proteins are proposed to participate in synap-
tic plasticity. A widely published “subunit rule” model posits
that protein interactions with the tail of GluR1 mediate hippo-
campal long-term potentiation by trafficking GluR1/2 heter-
omers, whereas proteins interacting with GluR2/3 heteromers
mediate hippocampal long-term depression (LTD; Shi et al.,
2001; Lee et al., 2004). However, genetic studies are generally
not in accord with the currently defined models. Mice lacking
GluR1 retain significant postsynaptic long-term potentiation dur-
ing development and in certain regions of mature hippocampus
(Zamanillo et al., 1999; Jensen et al., 2003). Mice lacking GluR3
or GluR2 can only express heteromers containing GluR1. That
these mice show normal LTD (Jia et al., 1996; Meng et al., 2003)
conflicts with the model that trafficking of GluR2/3 heteromers
mediates LTD. Even more problematic for such a model is that
mice lacking both GluR2 and GluR3, which form GluR1 ho-
momers, also show LTD (Meng et al., 2003). Although we can-
not fully discount the possibility that the currently defined sub-
unit rules play roles in specialized circumstances or in isolated
neuronal populations, they are not necessary for established plas-
ticity models in hippocampus, where they were initially reported.
Agreeing with previous studies (Rubio and Wenthold,
1999), we find a small population of AMPARs that associates
with the chaperone BiP. This population of subunits likely rep-
resents immature receptors, as BiP resides in the ER. Indeed,
previous studies suggested that a subpopulation of GluR2 sub-
units resides in a monomeric or dimeric state in the ER (Greger
et al., 2003). Accordingly, we find that the BiP-associated
GluR2 subunits are homomeric and are not associated with
other proteins. Association of AMPARs with TARPs is entirely
independent from their interaction with BiP. This may suggest
that TARPs displace BiP from GluR2 subunits to facilitate sur-
face trafficking. This would fit with our previous results show-
ing that TARPs facilitate AMPAR progression through the
secretory pathway (Tomita et al., 2003).
Data here also indicate that TARPs play roles beyond that
of chaperone, as TARPs remain associated with AMPARs at
the synapse. This work, together with the aforementioned ge-
netic studies by others, questions the general importance of
previously described non-TARP mechanisms for receptor traf-
ficking. These data establish a unique role for TARPs, as inte-
gral components essential for trafficking and synaptic function
of neuronal AMPARs.
Figure 4. Two distinct AMPAR complexes. Immunoaffinity-purified brain
AMPAR complexes (IAP) were reprecipitated (seqIP) with antibodies to
either BiP or TARPs and analyzed by silver staining (top) and immuno-
blotting with the indicated antibodies (bottom). The BiP reprecipitation
isolates 110- (arrow) and 78-kD (closed arrowhead; BiP) proteins; the
TARP reprecipitation isolates 110- and 35-kD (open arrowhead; TARPs)
proteins. The BiP reprecipitates include only GluR2, but not GluR1,
TARPs, or PSD-95, whereas TARP reprecipitates include GluR1 and PSD-95
in addition to GluR2. 
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Materials and methods
 
Antibodies
 
The following antibodies were used: rabbit polyclonal antibodies to
GluR1, GluR2/3, and GluR4 (Chemicon), TARPs (Tomita et al., 2003),
GRIP (a gift from R. Huganir, Johns Hopkins University, Baltimore, MD),
and NSF and PICK1 (Santa Cruz Biotechnology, Inc.); mouse monoclonal
antibodies to GluR2 (Chemicon), SAP97 and BiP (StressGen Biotechnolo-
gies), PSD-95 (MA1-046; Affinity BioReagents, Inc.), FLAG (M2), 
 
 
 
-tubulin
and AP-2 (Sigma-Aldrich), and 4.1N (BD Biosciences).
 
Generation of transgenic mice
 
CBP and FLAG peptide sequences were inserted after the signal sequence of
mouse GluR2 cDNA (CBP/FLAG-GluR2). For generation of transgenic mice,
cDNA of CBP/FLAG-GluR2 was subcloned into the Thy 1-expression cassette
(a gift from D. Monard, Friedrich Miescher Institut, Basel, Switzerland; Luthi et
al., 1997). Transgenic mice were generated by Y. Chen-Tsai (Stanford Trans-
genic Research Facility, Stanford, CA). Eight transgenic founders were crossed
with C57BL/6J mice to produce the CBP/FLAG-GluR2 transgenic lines.
 
Immunoprecipitation from mouse brain
 
Mouse brains were homogenized with buffer A (10 mM Tris-HCl, pH 8.0, 5
mM EDTA, 5 mM EGTA, 0.32 M sucrose, and 100 
 
 
 
g/ml PMSF). P2 mem-
brane fractions were solubilized with buffer B (20 mM Tris-HCl, pH 7.4, 150
mM NaCl, 1% Triton X-100, and 50 
 
 
 
g/ml PMSF) for 1 h. After centrifuga-
tion at 37,000 
 
g
 
 for 1 h, the extracts were precleared by the addition of pro-
tein A–Sepharose (Amersham Biosciences). The supernatant (
 
 
 
5–8 mg of
protein) was incubated with 5 
 
 
 
g of anti-GluR2 mAb (Chemicon) or anti-
TARP antibody for 2 h, and then with 50 
 
 
 
l of protein A–Sepharose for 1 h.
 
IAP of CBP/FLAG-GluR2
 
CBP/FLAG-GluR2 expressed in HEK cells (one 10-cm plate) was tandemly
purified using anti-FLAG M2 agarose and CaM Sepharose as described
previously (Yang et al., 2002), except for the use of Triton X-100 instead
of CHAPS. For purification of CBP/FLAG-GluR2 from transgenic mice,
forebrain extracts from wild-type or transgenic mice were prepared as de-
scribed in the previous section. Deoxycholate extraction followed the
method of Luo et al. (1997). Solubilized and precleared proteins (
 
 
 
5–8
mg protein) from P2 membrane fractions were incubated with 75 
 
 
 
l of
FLAG-M2 agarose (Sigma-Aldrich) for 2 h, washed with buffer B six times,
and eluted with 375 
 
 
 
l of 0.25 mg/ml FLAG peptide (Sigma-Aldrich) in
buffer B. Purified proteins were separated by SDS-PAGE and transferred
to PVDF membranes. Proteins on the membrane were visualized by colloi-
dal gold total protein stain (Bio-Rad Laboratories) or Western blotting
analysis. For quantitative Western blot analysis, CBP/FLAG-GluR2, HA-
GluR1, PSD-95-GFP, or SAP-97-GFP was expressed in HEK cells and
purified by immunoprecipitation with anti-FLAG, HA, or GFP antibody. Pu-
rified proteins were quantitated by Coomassie brilliant blue or gold colloi-
dal staining using BSA for calibration. Scanned signals were analyzed by
NIH Image software. For reprecipitation of BiP and TARP from immunoaf-
finity-purified AMPAR complexes, the IAP elution was incubated with anti-
BiP or anti-TARP antibody, and then with protein A–Sepharose.
 
Mass spectrometry analysis
 
The protein band migrating at 78 kD was excised from a silver-stained
gel, reduced with 10 mM dithiothreitol, and alkylated with iodoaceta-
mide. This extract was digested with trypsin (12 ng/
 
 
 
L) overnight at
37
 
 
 
C. The extracted peptides were then separated via HPLC using a re-
verse phase C-18 column (LC Packings) on a 1100 series HPLC (Agilent
Technologies). The LC eluent was coupled to a micro-ionspray source at-
tached to a QSTAR Pulsar mass spectrometer (MDS Sciex). 44 peptides
obtained from the 78-kD band were identified for BiP and these peptides
accounted for 57% of the entire BiP sequence (NP_005338).
 
Image acquisition
 
Microscopic image of hippocampal neurons was taken at RT using a fluo-
rescence microscope (Axiovert S100TV; Carl Zeiss MicroImaging, Inc.)
with a 20
 
 
 
/0.75 NA objective and a charge-coupled device camera
(model CA742-95; Hamamatsu) controlled by Metamorph software (Ver.
4.1.3; Universal Imaging Corp.). Adobe Photoshop was used for image
cropping and adjustment.
 
Electrophysiology
 
Electrophysiology using 
 
X. laevis
 
 oocytes was performed as described pre-
viously (Tomita et al., 2004). Electrophysiology in hippocampal slices was
performed as described previously (Schnell et al., 2002).
 
Online supplemental material
 
Fig. S1 shows the expression pattern of CBP/FLAG-GluR2 in generated
transgenic mice and efficient purification of CBP/FLAG-GluR2 from trans-
genic mouse brain. Fig. S2 shows protein composition of AMPAR com-
plexes purified from the deoxycholate-extracted brain. Online supplemen-
tal material is available at http://www.jcb.org/cgi/content/full/jcb.
200501121/DC1.
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